Lack of an atypical PDR transporter generates an immunogenic Cryptococcus neoformans strain that drives a dysregulated and lethal immune response in murine lungs

ABSTRACT Cryptococcus neoformans is an opportunistic fungal pathogen responsible for >150,000 deaths every year, with a mortality rate as high as 81%. This high medical burden is due, in part, to an incomplete understanding of its pathogenesis. In a previous study, we identified a cryptococcal at...

Full description

Saved in:
Bibliographic Details
Main Authors: Christopher J. Winski, Peter V. Stuckey, Armando M. Marrufo, Georgina Agyei, Robbi L. Ross, Tamanna Urmi, Sarah Chapman, Felipe H. Santiago-Tirado
Format: Article
Language:English
Published: American Society for Microbiology 2025-07-01
Series:mBio
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mbio.01321-25
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850100475353890816
author Christopher J. Winski
Peter V. Stuckey
Armando M. Marrufo
Georgina Agyei
Robbi L. Ross
Tamanna Urmi
Sarah Chapman
Felipe H. Santiago-Tirado
author_facet Christopher J. Winski
Peter V. Stuckey
Armando M. Marrufo
Georgina Agyei
Robbi L. Ross
Tamanna Urmi
Sarah Chapman
Felipe H. Santiago-Tirado
author_sort Christopher J. Winski
collection DOAJ
description ABSTRACT Cryptococcus neoformans is an opportunistic fungal pathogen responsible for >150,000 deaths every year, with a mortality rate as high as 81%. This high medical burden is due, in part, to an incomplete understanding of its pathogenesis. In a previous study, we identified a cryptococcal atypical Adenosine triphosphate (ATP)-binding cassette (ABC) pleiotropic drug resistance (PDR) transporter, PDR6, that affected antifungal resistance and host interactions. Here, we follow up on the role of PDR6 in cryptococcal virulence. In vivo, mice infected with the pdr6Δ strain display altered symptomatology and disease progression. Specifically, we observed a significant increase in the innate immune cell populations in the pdr6Δ-infected mice when compared with their WT-infected littermates. Furthermore, quantification of pulmonary cytokines/chemokines revealed a robust increase of pro-inflammatory cytokines in mice infected with the pdr6Δ mutant strain. Despite the documented sensitivity of the pdr6Δ strain to azole antifungal drugs, the treatment of pdr6Δ-infected animals with antifungals did not affect survival; however, treatment with a corticosteroid significantly extended survival, highlighting the importance of a balanced/controlled host immune response. Results with mice that mount opposing immune responses support our hypothesis that the pdr6Δ strain induces a hyper-inflammatory immune response and that the mice succumb to immune-dependent tissue damage rather than the fungal burden. This altered immune response is driven, in part, by changes in the mutant’s surface. Taken together, this study provides insights regarding cryptococcal pathogenesis and highlights additional functions of PDR-type ABC transporters in pathogenic fungi.IMPORTANCEYeasts of the Cryptococcus genus, especially C. neoformans, can cause disease with unacceptably high mortality. This is due to delays in diagnostics, ineffective treatments, and an incomplete understanding of the interactions between this fungus and our immune system. In this study, we expand our knowledge of the biological function of the PDR6 gene, particularly its effect on modulating the host’s immune response. Normally, C. neoformans infections are characterized by an anti-inflammatory response that is unable to control the yeast. In the absence of PDR6, the response to the infection is a dysregulated pro-inflammatory response that initially controls the fungi but eventually results in the death of the host due to too much tissue damage. This is due, in part, to an altered fungal surface. Given the dual role of PDR6 in modulating antifungal sensitivity and immune responses, this work provides important insights that may lead to new or improved therapeutics.
format Article
id doaj-art-8a44deb836fa46dbbcfbce2c58ed5fbe
institution DOAJ
issn 2150-7511
language English
publishDate 2025-07-01
publisher American Society for Microbiology
record_format Article
series mBio
spelling doaj-art-8a44deb836fa46dbbcfbce2c58ed5fbe2025-08-20T02:40:18ZengAmerican Society for MicrobiologymBio2150-75112025-07-0116710.1128/mbio.01321-25Lack of an atypical PDR transporter generates an immunogenic Cryptococcus neoformans strain that drives a dysregulated and lethal immune response in murine lungsChristopher J. Winski0Peter V. Stuckey1Armando M. Marrufo2Georgina Agyei3Robbi L. Ross4Tamanna Urmi5Sarah Chapman6Felipe H. Santiago-Tirado7Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USADepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USADepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USADepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USADepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USADepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USAIntegrated Imaging Facility, University of Notre Dame, Notre Dame, Indiana, USADepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USAABSTRACT Cryptococcus neoformans is an opportunistic fungal pathogen responsible for >150,000 deaths every year, with a mortality rate as high as 81%. This high medical burden is due, in part, to an incomplete understanding of its pathogenesis. In a previous study, we identified a cryptococcal atypical Adenosine triphosphate (ATP)-binding cassette (ABC) pleiotropic drug resistance (PDR) transporter, PDR6, that affected antifungal resistance and host interactions. Here, we follow up on the role of PDR6 in cryptococcal virulence. In vivo, mice infected with the pdr6Δ strain display altered symptomatology and disease progression. Specifically, we observed a significant increase in the innate immune cell populations in the pdr6Δ-infected mice when compared with their WT-infected littermates. Furthermore, quantification of pulmonary cytokines/chemokines revealed a robust increase of pro-inflammatory cytokines in mice infected with the pdr6Δ mutant strain. Despite the documented sensitivity of the pdr6Δ strain to azole antifungal drugs, the treatment of pdr6Δ-infected animals with antifungals did not affect survival; however, treatment with a corticosteroid significantly extended survival, highlighting the importance of a balanced/controlled host immune response. Results with mice that mount opposing immune responses support our hypothesis that the pdr6Δ strain induces a hyper-inflammatory immune response and that the mice succumb to immune-dependent tissue damage rather than the fungal burden. This altered immune response is driven, in part, by changes in the mutant’s surface. Taken together, this study provides insights regarding cryptococcal pathogenesis and highlights additional functions of PDR-type ABC transporters in pathogenic fungi.IMPORTANCEYeasts of the Cryptococcus genus, especially C. neoformans, can cause disease with unacceptably high mortality. This is due to delays in diagnostics, ineffective treatments, and an incomplete understanding of the interactions between this fungus and our immune system. In this study, we expand our knowledge of the biological function of the PDR6 gene, particularly its effect on modulating the host’s immune response. Normally, C. neoformans infections are characterized by an anti-inflammatory response that is unable to control the yeast. In the absence of PDR6, the response to the infection is a dysregulated pro-inflammatory response that initially controls the fungi but eventually results in the death of the host due to too much tissue damage. This is due, in part, to an altered fungal surface. Given the dual role of PDR6 in modulating antifungal sensitivity and immune responses, this work provides important insights that may lead to new or improved therapeutics.https://journals.asm.org/doi/10.1128/mbio.01321-25Cryptococcus neoformansfungal pathogenPDR transporterfungal immunity
spellingShingle Christopher J. Winski
Peter V. Stuckey
Armando M. Marrufo
Georgina Agyei
Robbi L. Ross
Tamanna Urmi
Sarah Chapman
Felipe H. Santiago-Tirado
Lack of an atypical PDR transporter generates an immunogenic Cryptococcus neoformans strain that drives a dysregulated and lethal immune response in murine lungs
mBio
Cryptococcus neoformans
fungal pathogen
PDR transporter
fungal immunity
title Lack of an atypical PDR transporter generates an immunogenic Cryptococcus neoformans strain that drives a dysregulated and lethal immune response in murine lungs
title_full Lack of an atypical PDR transporter generates an immunogenic Cryptococcus neoformans strain that drives a dysregulated and lethal immune response in murine lungs
title_fullStr Lack of an atypical PDR transporter generates an immunogenic Cryptococcus neoformans strain that drives a dysregulated and lethal immune response in murine lungs
title_full_unstemmed Lack of an atypical PDR transporter generates an immunogenic Cryptococcus neoformans strain that drives a dysregulated and lethal immune response in murine lungs
title_short Lack of an atypical PDR transporter generates an immunogenic Cryptococcus neoformans strain that drives a dysregulated and lethal immune response in murine lungs
title_sort lack of an atypical pdr transporter generates an immunogenic cryptococcus neoformans strain that drives a dysregulated and lethal immune response in murine lungs
topic Cryptococcus neoformans
fungal pathogen
PDR transporter
fungal immunity
url https://journals.asm.org/doi/10.1128/mbio.01321-25
work_keys_str_mv AT christopherjwinski lackofanatypicalpdrtransportergeneratesanimmunogeniccryptococcusneoformansstrainthatdrivesadysregulatedandlethalimmuneresponseinmurinelungs
AT petervstuckey lackofanatypicalpdrtransportergeneratesanimmunogeniccryptococcusneoformansstrainthatdrivesadysregulatedandlethalimmuneresponseinmurinelungs
AT armandommarrufo lackofanatypicalpdrtransportergeneratesanimmunogeniccryptococcusneoformansstrainthatdrivesadysregulatedandlethalimmuneresponseinmurinelungs
AT georginaagyei lackofanatypicalpdrtransportergeneratesanimmunogeniccryptococcusneoformansstrainthatdrivesadysregulatedandlethalimmuneresponseinmurinelungs
AT robbilross lackofanatypicalpdrtransportergeneratesanimmunogeniccryptococcusneoformansstrainthatdrivesadysregulatedandlethalimmuneresponseinmurinelungs
AT tamannaurmi lackofanatypicalpdrtransportergeneratesanimmunogeniccryptococcusneoformansstrainthatdrivesadysregulatedandlethalimmuneresponseinmurinelungs
AT sarahchapman lackofanatypicalpdrtransportergeneratesanimmunogeniccryptococcusneoformansstrainthatdrivesadysregulatedandlethalimmuneresponseinmurinelungs
AT felipehsantiagotirado lackofanatypicalpdrtransportergeneratesanimmunogeniccryptococcusneoformansstrainthatdrivesadysregulatedandlethalimmuneresponseinmurinelungs